1. Home
  2. WASH vs MLYS Comparison

WASH vs MLYS Comparison

Compare WASH & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Washington Trust Bancorp Inc.

WASH

Washington Trust Bancorp Inc.

HOLD

Current Price

$32.19

Market Cap

682.2M

Sector

Finance

ML Signal

HOLD

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$30.04

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WASH
MLYS
Founded
1800
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
682.2M
2.2B
IPO Year
1994
2023

Fundamental Metrics

Financial Performance
Metric
WASH
MLYS
Price
$32.19
$30.04
Analyst Decision
Hold
Strong Buy
Analyst Count
4
7
Target Price
$30.25
$48.67
AVG Volume (30 Days)
160.5K
1.1M
Earning Date
04-20-2026
05-06-2026
Dividend Yield
7.22%
N/A
EPS Growth
266.26
37.43
EPS
0.66
N/A
Revenue
$229,048,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.19
N/A
P/E Ratio
$48.94
N/A
Revenue Growth
127.57
N/A
52 Week Low
$25.23
$12.59
52 Week High
$37.08
$47.65

Technical Indicators

Market Signals
Indicator
WASH
MLYS
Relative Strength Index (RSI) 49.83 58.14
Support Level $31.51 $26.01
Resistance Level $32.49 $31.12
Average True Range (ATR) 0.75 1.66
MACD 0.14 0.10
Stochastic Oscillator 74.21 83.72

Price Performance

Historical Comparison
WASH
MLYS

About WASH Washington Trust Bancorp Inc.

Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

Share on Social Networks: